James Rodney Landreneau MD
Anterior Segment Related, Cataract Related, Cornea & External Disease
Ophthalmology Cornea and Refractive Fellow
Join to View Full Profile
3215 Wingate CtSte 102Columbia, MO 65201
Phone+1 573-884-3937
Fax+1 573-884-4868
Dr. Landreneau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- James Landreneau, MD, is an ophthalmologist based in Columbia, MO, specializing in cataracts, anterior segment, and cornea and external disease. He earned his MD from Louisiana State University School of Medicine in New Orleans in 2017 and completed his residency in Ophthalmology at the University of Missouri-Columbia in 2021. Dr. Landreneau furthered his training with a fellowship in Ophthalmology at the Medical University of South Carolina. His professional experience includes roles as an Ophthalmology Resident at University of Missouri Health Care since 2018 and a Clinical Fellow at the Medical University of South Carolina from 2021. His research contributions include publications focusing on gene therapy for corneal fibrosis, acrolein exposure effects, and factors affecting surgical outcomes in glaucoma treatments.
Education & Training
Medical University of South CarolinaFellowship, Ophthalmology, 2021 - 2022
University of Missouri-ColumbiaResidency, Ophthalmology, 2018 - 2021
Louisiana State University School of Medicine (Baton Rouge)Internship, Internal Medicine, 2017 - 2018- Louisiana State University School of Medicine in New OrleansClass of 2017
University of Pittsburgh School of EngineeringBS, Chemical Engineering, 2008 - 2013
Certifications & Licensure
MO State Medical License 2018 - 2027
LA State Medical License 2017 - 2026
SC State Medical License 2021 - 2023
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 1 citationsTopical Rho-Associated Protein Kinase Inhibitor HA1077 Reduces Rabbit Corneal Fibrosis and Neovascularization.Michael K Fink, Suneel Gupta, Rajnish Kumar, Prashant R Sinha, Lynn M Martin
Journal of Ocular Pharmacology and Therapeutics. 2025-12-18 - 14 citationsTissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.Rajiv R Mohan, Suneel Gupta, Rajnish Kumar, Nishant R Sinha, James Landreneau
The Ocular Surface. 2024-04-01 - 2 citationsToxicological effects of ocular acrolein exposure to eyelids in rabbits in vivo.Suneel Gupta, Lynn M Martin, Eric Zhang, Prashant R Sinha, James Landreneau
Experimental Eye Research. 2023-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
